rejuvant life tabs

Longevity supplements report: Seneque profile

Latest articles

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...

Capsida Biotherapeutics emerges from stealth with $140m

Versant Ventures and Westlake Village BioPartners launch next-generation gene therapy company with $50m series A; AbbVie collaboration provides $90m for gene therapies for CNS...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...
Rejuvant

Seneque’s supplement Elevant Prime seeks to promote vitality by recharging energy, repairing cells and rewinding age.

Over the coming weeks, we will be bringing you extracts of 11 company profiles from our Longevity Supplements Report. Each profile includes an assessment of Pre-Clinical and Clinical Studies, Safety and Risks, Target Market and Success Factors and the target Hallmark(s) of Aging for one of their key products.

We also study each company’s IP, team, UVP, product efficacy, competitive advantage, runway and inflection point, and much more. Here’s the lowdown on Seneque, makers of Elevant Prime, whose philosophy is that vitality isn’t just a mindset, but a state of cellular health.

To view a full size version of Seneque’s profile please click here.

Longevity Supplements 1.0 Seneque Summary
.

Seneque was founded in 2018 to address the fact that healthspan is no longer increasing in developed countries, despite longevity research highlighting the potential of natural molecules to extend both healthspan and lifespan. The name Seneque comes from Seneca the Younger, a Roman philosopher who encouraged people to discover vitality using their inner sources. This is exactly what Seneque has set out to do, by gathering a team of international biochemists and cellular metabolism scientists to pioneer research into cellular longevity.

Based in Switzerland and the US, Seneque brings the rigorous scientific approach and standards of research used in the pharmaceutical industry to the supplement market. The company believes in undertaking cutting-edge research to create next generation products that help people live in better health, for longer, with additional clarity on provenance, purity and clinical data to gain consumer trust.

Seneque’s founder, French entrepreneur Guillaume Bermond, was inspired to champion the development of natural molecules as health and longevity interventions after seeing NMN mitigate severe age-associated health problems that were afflicting his father. Mr Bermond has since expanded Seneque’s research focus to encompass cellular NAD+ metabolism more broadly, to discover health solutions that support not only longevity, but also vitality at any age.

Elevant

“Seneque’s scientifically rigorous approach is grounded in the most extensive clinical research program to analyse the health benefits of NMN in humans to date. This first-of-kind research will propel further development of NMN to support cardiovascular, cognitive, muscular, skin and immune health.”

One of Seneque’s key research partners is the Buck Institute for Research on Aging, a collective of the world’s top scientists in the field of aging, located in California. Seneque collaborates with the Buck Institute on a range of research programs to enhance the scientific body of knowledge around the efficacy of NMN on longevity. Seneque’s Scientific Advisory Board is headed by two recognised NAD+ experts. Its Chair is President of the Buck Institute, Dr Eric Verdin, and its Chief Scientist is Dr Alessia Grozio, a biologist who helped discover an NMN transporter that delivers the nucleotide directly into cells.

In early 2021, Seneque launched its first health and longevity supplement brand, Elevant. Elevant’s flagship product is Prime, a range of clinically tested NMN supplements that work directly within cells to deliver daily energy, power immunity and fight aging. Prime has received compelling safety endorsements in the form of Self-GRAS affirmation, and highly favourable results from a world-first OECD 408 toxicology study undertaken on Seneque’s proprietary form of NMN, called NMN-C®, which Prime contains.

Prime is currently available for purchase from Elevant’s website, elevant.co.

Seneque maintains strict control over every element of its production and manufacturing process, to ensure that all its products deliver what it believes to be the highest levels of quality available in NAD+ boosters today. The manufacturing process for Prime was developed over two years in Europe and was designed to be applied at a large enough scale to make high purity NMN affordable for consumers. Elevant products are made in Europe in cGMP-certified facilities, are gluten-free and suitable for vegans.

Elevant

Access to the report and a FREE executive summary can be found here, and check out our other supplements company profiles here.

Comment on this article

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...

Capsida Biotherapeutics emerges from stealth with $140m

Versant Ventures and Westlake Village BioPartners launch next-generation gene therapy company with $50m series A; AbbVie collaboration provides $90m for gene therapies for CNS...

Longevity supplements report: Vitalic

Currently in stealth, Vitalic is on a mission to transition longevity from the early adopters on to a mass market through best-in-class marketing. Over the...

FOXO exclusively licenses epigenetic clocks from UCLA

FOXO Technologies' exclusive licence of epigenetic clocks PhenoAge and GrimAge from UCLA could be an insurance game-changer. FOXO Technologies Inc has announced the licence of...

Longevity investment: small sums behind big ideas

Sonia Arrison talks about her journey to becoming an early stage investor and what longevity means to her. While longevity is now seeing increasing interest...
Supps report ad middle